How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Isothermal Thermocycler Market
- By Product Type: Real-Time Isothermal Thermocyclers, Conventional Isothermal Thermocyclers, Portable/Handheld Isothermal Thermocyclers, High-Throughput Isothermal Thermocyclers
- By Technology: Loop-Mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), Helicase-Dependent Amplification (HDA), Nucleic Acid Sequence-Based Amplification (NASBA), Strand Displacement Amplification (SDA)
- By End User: Clinical Diagnostics Laboratories, Research Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Government Research Institutes, Point-of-Care Testing Facilities
- By Application: Infectious Disease Diagnosis, Genetic Testing and Screening, Food Safety Testing, Environmental Monitoring, Agricultural Biotechnology
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Real-Time Isothermal Thermocyclers leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Isothermal Thermocycler Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Technology 5
End User 5
Application 5
Companies profiled
Bio-Rad Laboratories Inc.
Thermo Fisher Scientific Inc.
Qiagen N.V.
Eppendorf AG
Analytik Jena AG
Agilent Technologies Inc.
Takara Bio Inc.
Merck KGaA (MilliporeSigma)
PerkinElmer Inc.
Hologic Inc.
Becton
Dickinson and Company (BD)
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Bio-Rad Laboratories Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Thermo Fisher Scientific Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Qiagen N.V.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Eppendorf AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Analytik Jena AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Agilent Technologies Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Takara Bio Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Merck KGaA (MilliporeSigma)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →PerkinElmer Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Hologic Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Becton
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Dickinson and Company (BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Stilla Technologies
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →GeneReach Biotechnology Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →OptiGene Limited
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Amplyus
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,090M by 2033 · 9.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Real-Time Isothermal Thermocyclers56.1
- Conventional Isothermal Thermocyclers17.1
- Portable/Handheld Isothermal Thermocyclers11.5
- High-Throughput Isothermal Thermocyclers15.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,412M → $3,071M · 10.2%
Europe$984.4M → $1,876M · 8.4%
Asia Pacific$898.8M → $1,787M · 9.0%
Latin America$556.4M → $1,193M · 10.0%
Middle East and Africa$428.0M → $875.7M · 9.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.832026
9.842027
9.862028
9.852029
9.872030
9.892031
9.892032
9.922033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Bio-Rad Laboratories Inc.13.5
- Thermo Fisher Scientific Inc.25.4
- Qiagen N.V.8.4
- Eppendorf AG7.1
- Analytik Jena AG6.7
- Agilent Technologies Inc.10.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type20.3%
Technology23.8%
End User25.3%
Application30.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.9
- Europe21.3
- Asia Pacific20.3
- Latin America13.5
- Middle East and Africa9.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Bio-Rad Laboratories Inc. | 86 | 86 | 76 | 76 | 79 | 81 | 81 |
| Thermo Fisher Scientific Inc. | 73 | 92 | 83 | 79 | 76 | 69 | 79 |
| Qiagen N.V. | 69 | 64 | 64 | 83 | 70 | 66 | 69 |
| Eppendorf AG | 78 | 77 | 77 | 70 | 72 | 69 | 74 |
| Analytik Jena AG | 57 | 73 | 65 | 72 | 60 | 61 | 65 |
| Agilent Technologies Inc. | 54 | 56 | 57 | 53 | 66 | 68 | 59 |
| Takara Bio Inc. | 50 | 43 | 53 | 47 | 60 | 57 | 52 |
| Merck KGaA (MilliporeSigma) | 38 | 56 | 37 | 35 | 35 | 51 | 42 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Qiagen N.V.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories Inc. | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Thermo Fisher Scientific Inc. | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Qiagen N.V. | ✓ | − | ◐ | ✓ | ◐ | − |
| Eppendorf AG | ✓ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Analytik Jena AG | − | ◐ | ◐ | ✓ | − | − |
| Agilent Technologies Inc. | − | ◐ | ◐ | − | ◐ | − |
| Takara Bio Inc. | − | − | ◐ | − | ◐ | ◐ |
| Merck KGaA (MilliporeSigma) | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Bio-Rad Laboratories Inc.81
2Thermo Fisher Scientific Inc.79
3Eppendorf AG74
4Qiagen N.V.69
5Analytik Jena AG65
6Agilent Technologies Inc.59
7Takara Bio Inc.52
8Merck KGaA (MilliporeSigma)42
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Bio-Rad Laboratories Inc.Thermo Fisher Scientific Inc.
Challenger2
Strong scale, closing on the leaders.
Qiagen N.V.Eppendorf AG
Contender2
Focused players with pockets of strength.
Analytik Jena AGAgilent Technologies Inc.
Niche2
Specialists in a single segment or region.
Takara Bio Inc.Merck KGaA (MilliporeSigma)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Isothermal Thermocycler Market — a $370M beachhead inside a $6.05B market.
Beachhead (SOM)$370Mobtainable near-term
Serviceable (SAM)$2.19Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Real-Time Isothermal Thermocyclers
Best fit — highest urgency & budget in Product Type.
Economic buyer79 fit
Conventional Isothermal Thermocyclers
Strong fit — clear ROI and a fast path to value.
End user68 fit
Portable/Handheld Isothermal Thermocyclers
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Technology & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve22%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Isothermal Thermocycler Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified23%
Evaluation11%
Closed-won6%
$16.0KCAC
$81KLTV
5.1:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Isothermal Thermocycler Market is a high-growth opportunity — $7.46B by 2033, compounding at 11.6%.
TAM · 2025$3.11Btoday
TAM · 2033$7.46Bforecast
CAGR11.6%2027–2033
Cumulative$45.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.46BTotal addressable market
SAM$2.60BServiceable available market
SOM$498MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.6% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.46BLarge & growingTAM by 2033 at 11.6% CAGR
$2.60BServiceable nowreachable with today’s model
$498MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.82BBear7.5% CAGR
$7.46BBase11.6% CAGR
$9.55BBull15.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Technology optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Isothermal Thermocycler Market — a $9.16B market by 2033. Plan: grow share from 7.1% to 14.9%.
Market size · 2033$9.16Btotal addressable
Market CAGR7.8%2027–2033
Target share14.9%from 7.1% today
Revenue ambition$1.36Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.1% | 14.9% | On track |
| Revenue | $590M | $1.36B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 31.6% | 44.6% | On track |
| Customer retention | 86.3% | 93.3% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Technology capability
A defensible second engine — invest in Technology to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Technology
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $177M capacity & capability investment
- Greenlight bolt-on M&A in Technology
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Isothermal Thermocycler Market conversation — a $3.99B market you can size, segment and defend in minutes.
Market size · 2033$3.99Btotal opportunity
Growth6.5%CAGR to 2033
Addressable buyers911+accounts in scope
Typical ROI4.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.8×return on cost, year one
< 3 mopayback period
$70K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Bio-Rad Laboratories Inc.Thermo Fisher Scientific Inc.Qiagen N.V.Eppendorf AGAnalytik Jena AGAgilent Technologies Inc.Takara Bio Inc.Merck KGaA (MilliporeSigma)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Isothermal Thermocycler Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Isothermal Thermocycler Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Isothermal RT-LAMP Nucleic Acid Amplification Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportIsothermal Microcalorimetry Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportIsothermal Liquid Nitrogen Freezers Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportIsothermal Amplification Kit Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportIsothermal Amplification Enzymes Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportIsotetrandrine Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportIsosorbide Mononitrate Tablet Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportIsosorbide Mononitrate Sustained-release Tablet Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportIsosorbide Mononitrate Injection Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportIsosorbide Mononitrate API Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportIsosorbide Mononitrate and Glucose Injection Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportIsosorbide Dinitrate Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.